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Abstract
In the context of allogeneic bone marrow transplantation, an accurate estimate of the risk of developing graft-versus-host
 .  .disease GVHD is of major interest. The pre-transplant frequency of donor’s helper T-lymphocyte precursors HTLp
directed against host’s antigens may be helpful in predicting this risk. This technique relies on an indirect measurement of
 .interleukin-2 IL-2 secreted by the HTLp, as assessed by the proliferation of an IL-2 dependent cell line. Many authors use
the murine CTLL-2 cell line in this assay, but these cells do not respond to the presence of minute amounts of IL-2 in the
culture medium, and thus do not discriminate between the absence or the presence of very low levels of IL-2. We therefore
decided to compare CTLL-2 with another IL-2 dependent cell line, the murine A9.12 cell line. A comparison was made
 .using serial dilutions of recombinant human IL-2, limiting dilutions of baby hamster kidney BHK cells transfected with
human IL-2 gene and in the context of clinical tests performed for the detection of pre-transplant HTLp. Both the sensitivity
and reliability of the tests were better using A9.12. We conclude that the A9.12 cell line might be a more suitable tool for
pre-transplant HTLp determinations before allogeneic bone marrow transplantation or whenever low IL-2 levels are to be
measured. q 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
 .Allogeneic bone marrow transplantation BMT
has become a widely used treatment for both malig-
Abbreviations: BHK: baby hamster kidney; BMT: bone mar-
row transplantation; C.I.: confidence interval; CTLp: cytotoxic T
lymphocyte precursor; DMSO: dimethylsulfoxide; GVHD: graft-
versus-host disease; HLA: human leukocyte antigen; HTLp: helper
T lymphocyte precursor; IL-2: interleukin 2; IL-4: interleukin 4;
LDA: limiting dilution assay; MLR: mixed lymphocyte reaction;
SD: standard deviation
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nant and genetic blood disorders. Despite much
progress, BMT remains a risky treatment, mainly
due to graft rejection, opportunistic infections and
the potentially severe syndrome named graft-versus-
 . host disease GVHD Ferrara, 1994; Theobald, 1995;
.den Haan et al., 1995 .
Risk factors for GVHD such as disparities be-
tween donor and recipient for HLA antigens Brad-
.ley and Jeannet, 1993 , the use of an unrelated donor
 .Bearman et al., 1994 , sex mismatch, donor andror
 .recipient in an older age group Kalhs, 1993 and
previous infections with herpes viruses Bostrom et¨
al., 1992; Appleton and Sviland, 1993, Appleton et
0022-1759r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
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.al., 1995 are well established. Nevertheless, any
evaluation based on these general risk factors is
insufficient to predict GVHD in a given donor–re-
cipient pair.
To predict individual risk of GVHD after BMT,
functional in vitro tests have been designed. The
most widely used has been the mixed lymphocyte
 .reaction MLR . Nevertheless, there is no correlation
between a high response index measured by MLR
and post-transplant complications GVHD or rejec-
.  .tion de Gast et al., 1992; Hansen et al., 1995 .
 .Limiting dilution assays LDA estimating the fre-
quency of cytotoxic or helper T lymphocyte precur-
 .sors CTLp or HTLp have therefore been devel-
oped. These tests have been shown to give a better
prediction for GVHD or rejection Goulmy et al.,
1985; Kaminski et al., 1989; Theobald et al., 1992;
Batchelor et al., 1993; Nierle et al., 1993; Roosnek et
al., 1993; Schwarer et al., 1993; Theobald and Bun-
.jes, 1993; Bunjes et al., 1995 .
To estimate HTLp frequency, IL-2 secretion is
assessed by the proliferation of an IL-2 dependent
cell line. The CTLL-2 murine cell line is often used
for this purpose but we have noted that these cells
lack sensitivity. Therefore we have tested a modifica-
tion of the usual protocol to improve sensitivity and
reliability in the detection of IL-2 secreted by donor
anti-host HTLp: the use of the A9.12 murine cell line
 .a kind gift from Dr. C.C.Y. Shih instead of the
usual CTLL-2 cell line. We compared these two cell
lines for IL-2 detection in rhIL-2 serial dilutions,
BHK-pBEH limiting dilution supernatants and HTLp
supernatants.
2. Materials and methods
2.1. Har˝esting and cryopreser˝ation of donor and
patient cells
Heparinized blood from healthy volunteer donors
or from patients and their HLA-identical sibling
donor was separated on Ficoll-Hypaque densitys
.1.077, International Medical, Belgium , washed 3
times and cryopreserved in liquid nitrogen at 5=106
cellsrml in Dulbecco modified Eagle’s medium
 .DMEM; Gibco containing 20% heat-inactivated
normal AB human pooled serum, glutamine 1.5
.  . mM , penicillin 50 Urml , streptomycin 50
.  .mgrml , gentamycin 500 mgrml and 10%
dimethylsulfoxide.
2.2. CTLL-2 culture
The CTLL-2 cell line was maintained in DMEM
supplemented with 10% heat-inactivated fetal calf
 . serum, glucose 3.5 grl , 2-mercaptoethanol 2=
y5 .  .  .10 M , arginine 0.55 mM , asparagine 0.24 mM ,
 .  .glutamine 1.5 mM , hepes buffer 10 mM , peni-
 .  .cillin 50 Urml , streptomycin 50 mgrml , and
 .gentamycin 500 mgrml . Recombinant human IL-2
 w .Proleukin , Eurocetus was added to reach a final
concentration of 100 IUrml. Cells were fed every
two or three days and were not allowed to exceed the
maximal concentration of 4=105 cellsrml.
2.3. A9.12 culture
This murine helper T cell line was obtained from
an SJL anti-AKR limiting dilution microcytotoxicity
assay. The cells proliferated in response to alloanti-
gen, IL-2 or Con A. The response to antigen or
mitogen was abrogated by CsA and this abrogation
could be reversed by adding IL-2. This cell line was
maintained in culture for more than 1 year Shih et
.al., 1983 .
The A9.12 cell line was cultured in RPMI 1640
supplemented with 10% heat-inactivated fetal calf
 .  .serum, glutamine 1.5 mM , hepes buffer 10 mM ,
 . sodium pyruvate 2 mM , 2-mercaptoethanol 5=
y5 .  . 10 M , penicillin 50 Urml , streptomycin 50
.  .mgrml , and gentamycin 500 mgrml . IL-2 was
added to reach a final concentration of 100 IUrml.
Cells were fed every 2 or 3 days and were not
allowed to exceed the maximal concentration of
4=105 cellsrml. Population doubling occurred over
16 to 18 h. In the early subculturings, 2 ml aliquots
were frozen in complete culture medium containing
10% DMSO and were kept in liquid nitrogen until
used. About 3–4=106 cells were frozen in each
aliquot. Every 6 or 7 weeks, a new batch was started
by thawing a previously frozen aliquot to ensure that
all cells were IL-2 dependent.
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2.4. BHK culture
This cell line was a kind gift from Dr. H. Hauser.
It was transfected with the human IL-2 gene and was
found to secrete 4.5=103 unitsr106 cellsr24 h
 .Conradt et al., 1989 . This cell line was maintained
2  .in 25 cm culture flasks Falcon in the same medium
as the A9.12 cell line, except for IL-2 addition. The
population doubling time was 14 to 16 h. Every 2 or
3 days, cells were trypsinized to separate them from
the culture flask, washed 3 times and subcultured.
Culture supernatant was filtered through 0.45 mm
 .filter Millipore and kept at y708C until used.
These three cell lines were kept in an humidified
atmosphere with 5% CO at 378C.2
2.5. Limiting dilution assay with BHK-IL-2 secreting
cells
BHK cells were harvested from the culture flasks,
washed three times and diluted to obtain 1.25=104
cellsrwellr100 ml. This solution was then serially
 .two-fold diluted in flat-bottomed plates Falcon with
the last dilution containing 0.1 cellrwell. Sixteen
replicates were set up for each dilution. The limiting
dilution plates were incubated for 5 h at 378C and
were then frozen until analysed for IL-2 content.
2.6. Limiting dilution assay for HTLp frequency
determination
All cells used in the HTLp assay were thawed on
the test day and washed 3 times. Responding cells
from the bone marrow donor were diluted to obtain a
final concentration of 8=104 cellsrwellr100 ml.
These cells were plated in round-bottom plates and
serially two-fold diluted with the last dilution at
2.5=103 cellsrwell. Stimulating cells from the pa-
tient were irradiated 20 Gy, rate: 29.6 Gyrmin,
137 . 5source of g radiation: Cs and 10 cells were
added in 100 ml to responding cells. Twenty-four
replicates of each dilution were set up, and also 24
replicates with stimulator cells alone for determina-
tion of positivity threshold, and 16 replicates with
responder cells alone. The stimulating capacity of
patient cells was evaluated with 16 replicates con-
taining responding cells from two unrelated, HLA
mismatched healthy volunteer controls. The respond-
ing capacity of donor cells was evaluated with the
same controls irradiated to serve as stimulator cells.
The cultures were performed in DMEM medium
supplemented with 10% heat-inactivated normal AB
 .human pooled serum, glutamine 1.5 mM , penicillin
 .  .50 Urml , streptomycin 50 mgrml , and gen-
 .tamycin 500 mgrml . Cells were kept in an humidi-
 .fied atmosphere 5% CO , 378C for 72 h. After2
72 h, 100 ml of the supernatant were removed in
new, flat-bottom plates and frozen at y708C for
further analysis. In some experiments, instead of
removing supernatants, the plates were irradiated
 .25 Gy to prevent lymphocyte proliferation before
the indicator cell line was added for the determina-
tion of IL-2 in the microcultures.
On the day of analysis, plates containing the
supernatants were slowly thawed 48C for 6 h, 378C
.for 30 min . During this time, IL-2 dependent cells
were washed three times in 50 ml culture medium,
counted, diluted to obtain a final concentration of
4=103 cellsrwellr50 ml and added to the super-
natants. A9.12 cells were diluted in an enriched
medium normal culture medium supplemented with
7 mM sodium pyruvate and 3 mM 2-mercapto-
.ethanol . In some experiments, A9.12 cells were
starved during 5"1 h before being added to the
supernatants. They were incubated in a humidified
 .atmosphere 5% CO , 378C for 24 or 42 h, follow-2
ing experiments, with the last 18 h in the presence of
2 mCirwell of 3H-thymidine. Thymidine incorpora-
tion was measured by harvesting cells to filters and
counting b radiation with a b scintillation counter
Beckman LS 6000 SE or Topcount, Packard Instru-
.ments .
2.7. IL-2 or IL-4 detection within serial dilutions
Two-fold serial dilutions of rh IL-2 or rh IL-4
 .Genzyme, Belgium were prepared in triplicate in
100 ml of HTLp culture medium. The dilutions
started with an IL-2 concentration of 500 IUrml to
reach 0.03 IUrml or with an IL-4 concentration
from 5000 IUrml to 0.02 IUrml. Plates containing
dilutions to be tested were frozen at y708C until
used. On the test day, these plates were slowly
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 .thawed 48C for 6 h, 378C for 30 min and treated in
the same way as the LDA supernatants.
2.8. Statistical analysis
Evaluations of HTLp frequency were obtained
using the x minimalisation for the zero term of the2
Poisson distribution between the number of respon-
der cells and the fraction of negative wells Taswell,
.1981, 1984 . The result was calculated with GLIM
 .software NAG, Oxford, UK . p values )0.1 were
considered as fitting the Poisson model.
In HTLp tests, the threshold of positivity for IL-2
secretion was calculated from the 24 replicates set up
 . 3  .  .Fig. 1. a A total of 4=10 A9.12 cells were incubated for 24 h after being starved open circles or not full triangles and proliferation
was measured by 3H-thymine incorporation. Each point represents the mean of three separate experiments and the bar indicates one standard
 . 3  .  .deviation. b A total of 4=10 A9.12 cells were incubated for 42 h after being starved open circles or not full triangles , and
proliferation was measured by 3H-thymidine incorporation. Each point represents the mean of three separate experiments and the bar
indicates one standard deviation.
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without responder cells as follows: percentile 75q
 .percentile 75ypercentile 25 .
Comparisons of the mean sensitivity of A9.12 and
CTLL-2 cells were made using the Mann–Whitney
rank test.
3. Results
Although the CTLL-2 line is well known and
 .described Gillis et al., 1978 , we needed to deter-
mine optimal conditions for the use of the A9.12 cell
 . 3  .  .Fig. 2. a A total of 4=10 A9.12 cells were incubated in IL-2 dilutions for 24 triangles or 42 h circles , after they had been starved, and
proliferation was measured by 3H-thymidine incorporation. Each point represents the mean of three separate experiments and the bar
 . 3  .  .indicates one standard deviation. b A total of 4=10 A9.12 cells were incubated in IL-2 dilutions for 24 triangles or 42 h lozenges ,
without starving, and proliferation was measured by 3H-thymidine incorporation. Each point represents the mean of three separate
experiments and the bar indicates one standard deviation.
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line to detect IL-2. We evaluated the cell number
that would give a good sensitivity, the starvation
period and the total incubation time to detect IL-2
with the highest discriminatory power, and also the
best correlation with IL-2 in the culture wells. We
finally ensured that A9.12 cells did not proliferate in
response to human IL-4.
3.1. Star˝ation of sensiti˝e cells
We compared the use of the A9.12 cell line with
or without starvation before adding the cells to IL-2
dilutions. A total of 4=103 A9.12 cells were incu-
 .  .bated for 24 Fig. 1a or 42 h Fig. 1b , after being
starved for 5"1 h or not. If the total incubation time
was 24 h, there was an elevated background, and the
discrimination power in the first part of the curve
 .was lower. If cells were incubated for 42 h Fig. 1b ,
there was little difference between starved or fed
cells. The dosage range was larger for cells that were
not starved, but with these culture conditions, there
was more variation between wells and between dif-
ferent experiments. We therefore decided to work
with starved cells.
3.2. Incubation time
We compared two different incubation times: 24 h
 .which is often used with the CTLL-2 cell line or
42 h. Fig. 2a and b show results obtained in three
distinct experiments. Proliferation of 4 = 10 3
cellsrwell was measured after 24 or 42 h of incuba-
 .tion in IL-2 dilutions, with Fig. 2a or without
 .Fig. 2b starving. With 24 h incubation, cells that
were not starved did not exhibit enough sensitivity
 .elevated background, weak slope of the curve . The
small IL-2 concentrations were detected, but there
was a plateau effect at lower concentrations com-
pared to cells incubated for 42 h. There were also
greater intra- and interassays variations when cells
were incubated for 24 h only.
3.3. Number of cells required
We plated 1–16=103 cells in serial IL-2 dilu-
tions after they had been starved for 5"1 h, and
allowed them to grow for 42 h. Fig. 3 shows prolif-
eration in response to IL-2. Obviously, 1=103 or
2=103 cells were associated with less sensitivity
than 4=103 cells. A total of 4=103 cells re-
Fig. 3. About 1–16=103 A9.12 cells were incubated in IL-2 serial dilutions for 42 h after being starved, and proliferation was measured by
3H-thymidine incorporation. Each point represents the mean of three separate experiments.
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Fig. 4. A total of 4=103 A9.12 cells were incubated for 42 h in the presence of rhIL-4 serial dilutions, and proliferation was measured by
3H-thymidine incorporation. Each point represents the mean of three separate experiments and the bar indicates one standard deviation.
sponded to a wider range of IL-2 concentrations no
.maximum effect until approximately 50 IUrml .
When a larger number of cells was used, the maxi-
mal proliferation was proportional to the cell num-
ber, but occurred within the same range of IL-2
 .concentration about 50 IUrml . On the other hand,
 .the first part of the curve from 0.2 to 7 IUrml was
almost the same with 4=103, 8=103 or 16=103
cells per well. Thus, for the measurement of small
amounts of IL-2, we did not increase the cell number
3   .Fig. 5. A total of 4=10 cells were incubated in IL-2 dilutions for 24 h in the case of CTLL-2 open circles , and 42 h in the case of
 .. 3A9.12 full triangles , and proliferation was measured by H-thymidine incorporation. Each point represents the mean of eight separate
experiments.
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beyond 4=103 per well. If IL-2 concentrations in
the range 10–500 IUrml were to be measured, it
would be preferable to use 16=103 cells or more
per well.
3.4. Sensiti˝ity to rhIL-4
Some authors have reported a sensitivity and
growth dependence of CTLL-2 to human IL-4 Menu
.et al., 1990; Theobald and Bunjes, 1993 . To ensure
that A9.12 cells did not grow in response to this
cytokine, we performed serial dilutions of IL-4 as we
did for IL-2 and tested 4=103 A9.12 cells growth
within 42 h. Fig. 4 shows that there was no relation-
ship between rhIL-4 concentration and A9.12 prolif-
eration, in comparison with that obtained with IL-2.
3.5. Sensiti˝ity of IL-2 dependent cell lines
Fig. 5 compares the two IL-2 sensitive cell lines.
A total of 4=103 cells were plated in IL-2 dilutions
and incubated for 24 h for CTLL-2 or for 42 h for
A9.12 this cell line having been starved for 5"1
.h . The sensitivity of eight cell batches derived from
different frozen aliquots was measured. The total
observation period lasted for at least 6 months. Over
this period, A9.12 cells proved more sensitive than
CTLL-2, especially at low concentrations, with lower
background and higher maximal proliferation. The
dose-proliferation plot showed a longer linear por-
tion with the A9.12 cell line from 0.06 to 100
.IUrml vs. 1 to 100 IUrml for CTLL-2 , permitting
dosage over a wider concentration range. IL-2 detec-
tion given by the first dilution that stimulated higher
.proliferation than the background was always better
with A9.12 cells 0.05 IUrml vs. 1.22 IUrml,
.  .p-0.001, Mann–Whitney rank test Table 1 .
In Fig. 6, the distribution of proliferating A9.12 or
CTLL-2 cultures in response to low doses of rhIL-2
 .0 or 0.5 IUrml is shown. The data were pooled
from sixteen separate experiments. CTLL-2 cells
responded in a largely overlapping fashion to 0 or
 .0.5 IUrml of IL-2 Fig. 6a . Conversely, the A9.12
cell line proliferated at completely distinct levels in
 .response to 0 or 0.5 IUrml Fig. 6b . These data
demonstrated again the greater sensitivity of the
A9.12 cell line to small amounts of IL-2.
3.6. Reproducibility of IL-2 detection
Table 1 represents batch-to-batch variability in
IL-2 detection for the two cell lines. Maximal and
minimal proliferation were compared for the two cell
Table 1
Batch-to-batch reproducibility of IL-2 detection
3 3  .H-TDR incorporation in H-TDR incorporation in IL-2 detection IUrml
medium with 100 IUrml medium with 0 IUrml
 .  .rhIL-2 cpm rhIL-2 cpm
CTLL-2 A9.12 CTLL-2 A9.12 CTLL-2 A9.12
Batch 1 33 821 99 438 1349 747 0.48 0.06
Batch 2 58 995 92 293 1639 863 0.48 0.06
Batch 3 48 305 106 681 2203 423 0.73 0.03
Batch 4 62 952 92 736 1299 345 1.80 0.03
Batch 5 90 025 71 005 8356 733 0.45 0.12
Batch 6 62 490 82 817 3234 530 1.80 0.03
Batch 7 35 878 127 317 3282 381 3.60 0.06
Batch 8 44 388 74 113 11 430 100 0.45 0.03
Mean 54 607 93 300 4099 515 1.22 0.05
SD 18 254 18 324 3748 254 1.12 0.03
SDrmean 33% 20% 91% 49% 92% 59%
 .Eight batches were analysed for minimal and maximal proliferation in response to known IL-2 amounts 0 or 100 I.U.rml as described for
 .Fig. 5. Triplicate cultures were analysed from each batch. Mean and standard deviation SD were calculated from the eight batches. IL-2
detection was indicated by the first dilution that stimulated higher proliferation than the background obtained in wells with culture medium
 .only meanq3 SD .
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 .  .Fig. 6. Proliferation of individual cultures of CTLL-2 panel A or A9.12 panel B in response to 0 or 0.5 IUrml rhIL-2. Proliferation was
measured by 3H-thymidine incorporation after 24 or 42 h incubation. Data are pooled from 16 separate experiments.
lines. More important batch-to-batch differences were
observed with CTLL-2 cells vs. A9.12 cells, with an
elevated ratio of standard deviation to mean 33% vs.
20% for maximal proliferation, 91% vs. 49% for
.background, respectively . IL-2 detection was less
reproducible with CTLL-2 cells ratio of standard
.deviation to mean: 92% vs. 59% for A9.12 .
All these experiments led us to choose the follow-
ing experimental conditions to measure IL-2 produc-
tion in HTLp supernatants: starving cells for 5"1 h,
total incubation time of 42 h, and the use of 4=103
cells per well.
Next, we ensured that this cell line could detect
IL-2 secretion from a single cell. For this purpose, a
BHK cell line transfected with the human IL-2 gene
was plated in limiting dilution experiments. We then
compared the A9.12 cell line with the CTLL-2 cell
line for IL-2 detection in these assays.
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Table 2
Comparison of the ability to detect one IL-2 secreting cell in
limiting dilution experiments set up with a transfected BHK cell
line
y1  .BHK cell frequency 95% confidence interval
CTLL-2 A9.12
 .  .Expt 1 2.68 1.94–3.7 0.18 0.13–0.26
 .  .Expt 2 10.6 7.1–15.7 1.83 1.32–2.53
 .Expt 3 y 1.54 1.2–2.3
BHK cells were incubated in limiting dilution numbers from
4 . 31.25=10 to 0.1 cells per well for 5 h. A total of 4=10 A9.12
or CTLL-2 cells were added to LDA plates, incubated for 24 or 42
h, and proliferation was measured by 3H-thymidine incorporation.
BHK frequency was estimated with the zero term of Poisson law.
3.7. Capacity to measure IL-2 in IL-2-producing-
BHK limiting dilution supernatants
To assess whether the two cell lines were able to
detect IL-2 production from one IL-2 secreting cell,
we set up limiting dilution experiments with a trans-
fected BHK cell line that was producing glycosy-
lated human IL-2 at high levels Conradt et al.,
.1989 . The same experiments were done three times
to ensure reproducibility. The A9.12 cell line was
clearly able to detect a single IL-2 producing cell,
 .but this was not the case with CTLL-2 Table 2 .
3.8. Capacity to measure IL-2 in HTLp supernatants
3.8.1. Positi˝ity threshold determination
Our final aim was to evaluate pretransplant HTLp
frequency with the greatest sensitivity and reliability.
This frequency is calculated using the ratio of nega-
tive cultures to the total number of cultures for a
given number of responder cells. Thus, the determi-
nation of the positivity threshold is of crucial impor-
tance. In the negative control wells, the majority of
cultures could not support A9.12 cell growth, but
some ‘outlier’ wells displayed 3H-thymidine incor-
3  .poration as high as 8=10 cpm data not shown .
When we calculated the positivity threshold by
adding three standard deviations to the mean of the
negative control wells, we obtained very high values.
These threshold values were also very different from
one experiment to another. Accordingly we chose to
calculate the positivity threshold with the outlier
 .labelling method Iglewicz and Hoaglin, 1993 . This
is based on the median negative value observed and
accounts for the false positive values, but is less
influenced by them.
3.8.2. Comparison between supernatant remo˝al and
second irradiation
As IL-2 detection is based on cell line prolifera-
tion, it is important to avoid any proliferation from
alloreactive lymphocytes in the HTLp assay. For this
purpose, some authors perform a second irradiation
of LDA plates Schwarer et al., 1993; Gribben et al.,
.1996; Potolicchio et al., 1996 . Other investigators
harvest supernatant and add this directly to the indi-
 .cator cell line Theobald et al., 1992 or freeze it
Schanz et al., 1994; Bouma et al., 1996; Lewalle et
al., 1996; Young et al., 1996; van der Meer et al.,
.1997 . This method permits an easier management of
LDA experiments.
Second irradiation or supernatant freezing was
compared for the A9.12 and CTLL-2 cell lines.
HTLp frequency was determined in one HLA fully
mismatched healthy donor pair. Four identical sets of
limiting dilution plates were set up to permit compar-
Table 3
HTLp assay with one HLA incompatible healthy control pair was performed in four sets. After 72 h incubation of alloreactive lymphocytes,
either a second irradiation or supernatant removal and freezing was performed. Then 4=103 IL-2 sensitive cells were added to the LDA
 .  . 3plates, incubated for 24 CTLL-2 or 42 h A9.12 , and proliferation was measured by H-thymidine incorporation. HTLp frequency was
estimated with the zero term of Poisson law
y3  .1rHTLp frequency 10 95% confidence interval
CTLL-2 A9.12
 .  .  .a Irradiated plates 27.4 20.2–37.2 6.4 4.7–8.7
 .  .  .b Frozen supernatants 25.2 19–33.5 4.5 3.3–6.1
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ison under identical conditions. Table 3 shows the
results obtained: for each cell line, the HTLp fre-
quency is equivalent, with 95% confidence intervals
largely overlapping either when supernatants were
removed and frozen or when plates were irradiated
again. Here also, the A9.12 cell line proved to be
more sensitive, detecting four-fold higher HTLp fre-
quencies. As supernatant freezing was far easier to
manage, allowing many plates to be analysed on the
same day, this method was chosen for all HTLp
experiments.
3.8.3. Ability to measure IL-2 in supernatants from
HTLp assays
The CTLL-2 or A9.12 cell lines were used to
estimate HTLp frequency from 107 different donor-
recipient pairs healthy controls or patients with blood
.  .disease . Table 4 part 1 shows that CTLL-2 gave
numerous problems: absence of proliferation in 48%
of the experiments and poor concordance with the
zero term of Poisson law in 40% of the experiments.
Conversely, the A9.12 cell line never failed to re-
spond to IL-2 present in culture supernatants. More-
over the concordance with Poisson law was obtained
in 81% of the experiments.
Twenty-six experiments were set up to determine
donor anti-host pretransplant HTLp frequency for
bone marrow recipients. The results obtained were
compared with the occurrence of acute GVHD Ta-
.ble 4, part 2 . When CTLL-2 cells were used as the
indicator cell line, there was an important lack of
specificity in predicting GVHD 20% vs. 71% for
.the A9.12 cell line . Poor predictive values were
obtained 43% for positive predictive values, 50%
for negative predictive values, compared to 80 and
.71% for A9.12 cells, respectively .
Sensitivity for HTLp detection was compared for
the two cell lines in 84 HTLp experiments 59 with
.  .A9.12 and 25 with CTLL-2 Table 4, part 3 . The
threshold for HTLp detection that is proliferation in
.negative controls was calculated for these experi-
ments. Median background proliferation was higher
with CTLL-2 cells 3346 cpm vs. 2652 cpm with
.A9.12 cells . Median proliferation in microcultures
from the dilution containing one HTLp per well was
calculated. Higher responses were obtained with
 .A9.12 cells 5858 cpm vs. 4841 for CTLL-2 . Thus a
better discrimination between positive and negative
microcultures was obtained ratio of proliferation in
positive wells relative to negative control wells: 1.44
.for the CTLL-2 cell line, 2.2 for the A9.12 cell line .
Table 4
Helper T lymphocyte precursor frequency was estimated in healthy volunteers and in prospective BMT patients with the A9.12 or the
CTLL-2 lines
Cell line used for IL-2 detection
CTLL-2 A9.12
 .  .Part 1 Nr. LDA experiments without cell proliferation in positve controls 23r48 48% 0r59 0%
 .  .Nr. LDA experiments not matching the zero term of Poisson law 10r25 40% 11r59 19%
 .  .Nr. LDA experiments matching the zero term of Poisson law 15r25 60% 48r59 81%
 .  .  .Part 2 Low HTLp frequency—GVHD 0–I true negative 1r9 11% 5r17 32%
 .  .  .Low HTLp frequency—GVHD II–IV false negative 1r9 11% 2r17 11%
 .  .  .High HTLp frequency—GVHD 0–I false positive 4r9 44% 2r17 11%
 .  .  .High HTLp frequency - GVHD II–IV true positive 3r9 33% 8r17 47%
 .  .Sensitivity 3r4 75% 8r10 80%
 .  .Specificity 1r5 20% 5r7 71%
 .  .Positive predictive value 3r7 43% 8r10 80%
 .  .Negative predictive value 1r2 50% 5r7 71%
 .Part 3 Threshold of HTLp detection median cpm 3346 2652
 .Proliferation in one HTLp containing culture well median cpm 4841 5858
 .Part 1: Validity of HTLp experiments data from 107 experiments .
 .Part 2: Use of pretransplant HTLp results in BMT patients for GVHD prediction data from 26 experiments .
 .Part 3: Capacity to proliferate in response to IL-2 produced by a single HTLp data from 84 experiments .
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4. Discussion
The CTLL-2 cell line is widely used to detect
IL-2 in culture supernatants. As also noted by We-
 .ston and Farrell 1996 , we observed that the sensi-
tivity of this cell line is not stable over time, espe-
 .cially following subculturing data not shown .
Moreover, in many HTLp supernatants, this cell line
was unable to detect the small amounts of IL-2
produced. As this test was performed only once due
.to the large number of patient’s cells required , it
was essential to detect IL-2 in the supernatants by
the most accurate method. The A9.12 cell line met
these requirements of sensitivity and reproducibility
and therefore its use should be recommended when-
ever the IL-2 levels are very low. Other investigators
 .Lewalle et al., 1996; Keever-Taylor et al., 1997
have used it with success in HTLp detection assays.
The greater sensitivity of A9.12 might explain the
proliferation observed in some negative control wells
in the HTLp test. Some stimuli other than allogeneic
cell recognition might be associated with these cul-
tures. For instance, there might be recognition of
allogeneic serum proteins present in the culture
medium. The irradiation stress might also provoke
release of a small amount of IL-2. This was shown in
 . vivo Xun et al., 1994 as well as in vitro Galdiero
.  .et al., 1994 . Hornick et al. 1997 also noted a
source of ‘unwanted’ IL-2 both in the stimulating
and in the responding population. They also noted a
‘back stimulation’ of stimulating cells activated by
alloantigens from responder cells, leading to poor
concordance with single-hit kinetics. To avoid these
IL-2 sources, they depleted the responding popula-
tion of HLA class II positive cells and the T cells
from the stimulating population. These depletions
allowed HTLp to achieve better concordance with
the single-hit model. On the other hand, this led to a
decrease of sensitivity and an increase of the number
of stimulating cells required for the successive rounds
of depletion. Moreover, this model deviates from the
in vivo conditions encountered in bone marrow or
solid organ transplantation.
Rather than performing depletions, we changed
the determination of the positivity threshold. The
new method of calculation takes into account the
median proliferation rather than the mean because
the mean showed larger variations due to a few
elevated values. Thus, the outlier labelling method
was chosen. It gave a better inter experimental stabil-
ity in positivity thresholds. Using this cell line, the
number of cells, the starving duration and the incuba-
tion time were critical.
An accurate measurement of IL-2 might also prove
useful in the evaluation of patients suffering from
other immunological diseases such as AIDS, in which
IL-2 plays an important role Westendorp et al.,
1994; Brinchmann et al., 1994; Collette et al., 1996;
.Yoo et al., 1996 . In kidney and cardiac allografts,
local and systemic IL-2 production has been corre-
lated with rejection episodes and indicates the need
to continue immunosuppression Muluk et al., 1991;
.Schulick et al., 1993; DeBruyne et al., 1995 . There
is also an increasing interest in IL-2 dosage in
autoimmune diseases such as multiple sclerosis, thy-
roiditis, myasthenia gravis, type I diabetes, thrombo-
cytopenic purpura Burns and Littlefield, 1993; De
Maria et al., 1994; Lohr et al., 1994; Yi et al., 1994;
.Rep et al., 1996; Semple et al., 1996 . The follow-up
of IL-2 and other cytokines in all these diseases
might permit a better understanding of the pathologi-
cal processes and lead to better disease management.
In conclusion, we have established that the A9.12
line is preferable for detecting low IL-2 production
in the HTLp assay compared to the conventionally
used CTLL-2 cell line.
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